Samia Qader

Preoptima is a cutting-edge platform that integrates real-time whole life carbon assessments and carbon optioneering into the early stages of building design. Using sophisticated AI algorithms and generative design, Preoptima offers a unique, iterative approach to designing low-carbon buildings as early as the conceptual design stage. No more steep learning curves or tedious data input; with Preoptimas algorithm you can dive straight into data-driven design choices, optioneer quickly, and pivot efficiently. Born from over a decade of academic research, Preoptima makes accurate carbon assessments accessible to all building stakeholders - transforming how the industry approaches sustainable building design.  See our website for more. We have representatives in the UK, US, EU and APAC regions.

Angel Investor

Preoptima is a cutting-edge platform that integrates real-time whole life carbon assessments and carbon optioneering into the early stages of building design. Using sophisticated AI algorithms and generative design, Preoptima offers a unique, iterative approach to designing low-carbon buildings as early as the conceptual design stage. No more steep learning curves or tedious data input; with Preoptimas algorithm you can dive straight into data-driven design choices, optioneer quickly, and pivot efficiently. Born from over a decade of academic research, Preoptima makes accurate carbon assessments accessible to all building stakeholders - transforming how the industry approaches sustainable building design.  See our website for more. We have representatives in the UK, US, EU and APAC regions.

Climate change is an existential threat but also our greatest opportunity. We are on the lookout to support and fund early-stage UK-based climate startups. We make sure to invest in the long term, providing space and opportunity for the people at the forefront of innovation. Potential Climate Ventures F1 Limited (PCV) is an appointed representative of SFC Capital Partners Ltd which is authorised and regulated by the Financial Conduct Authority (‘FCA’) in the United Kingdom (FRN 736284)

Bypath is a platform to connect people suffering from mast cell issues with medical practitioners.

Angel Investor